| Linda Smith, LCSW | |
|
4001 Commercial Center Dr Ste 2, Marion, AR 72364-9616 | |
| (870) 732-7920 | |
| (870) 732-7923 |
| Full Name | Linda Smith |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 4001 Commercial Center Dr Ste 2, Marion, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689028144 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 6712-C (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Linda Smith, LCSW 2809 Forest Home Rd, Jonesboro, AR 72401-5320 Ph: (866) 972-1268 | Linda Smith, LCSW 4001 Commercial Center Dr Ste 2, Marion, AR 72364-9616 Ph: (870) 732-7920 |
News Archive
After mild traumatic brain injury (TBI), a molecule called complement factor C1q may play a role in the secondary effects of brain injury, such as sleep disruption, epileptic activity, and inflammation, according to a new study in mice.
Silence Therapeutics plc, a leading global RNA interference (RNAi) therapeutics company, and InteRNA Technologies B.V., a biopharmaceutical company developing pathway targeted microRNA-based therapeutics for cancer, today announce that they have entered into an agreement to develop novel microRNA therapeutics for the treatment of cancer.
Personalized medicine or "precision medicine" is the most significant trend in 21st century medicine. "It's all about the right treatment for the right patient at the right time," says Ursula Schmidt-Erfurth, Head of MedUni Vienna's Department of Ophthalmology and Optometry.
Medivir AB announced today that the Russian Ministry of Health has approved Sovriad (simeprevir) for the treatment of chronic hepatitis C genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adults with compensated liver disease (including cirrhosis) who are treatment naïve or who have failed previous interferon therapy (pegylated or non-pegylated) with or without ribavirin. Russia will be the first country within EMEA to gain access to simeprevir, which represents a significant advance in hepatitis C treatment.
The U.S. Food and Drug Administration (FDA) yesterday in a press release informed about the approval of Imbruvica (ibrutinib) for the treatment of adult patients with chronic graft versus host disease (cGVHD) who have previously failed with one or more treatment. This is the first drug that the FDA has given its approval to in this disease condition.
› Verified 3 days ago
Lenora Coleman, THERAPIST Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 210 Manor St, Marion, AR 72364 Phone: 870-739-6818 Fax: 870-739-1970 | |
Kelly Guidroz, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4001 Commercial Center Dr Ste 2, Marion, AR 72364 Phone: 870-735-4441 Fax: 870-735-5441 | |
Mrs. Kristin Irene Young, MSSW LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 106 Cypress Ave, East Arkansas Youth Services, Marion, AR 72364 Phone: 870-739-4219 | |
Dorothy Anna Mae Donelson, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4001 Commercial Center Dr Ste 2, Marion, AR 72364 Phone: 870-735-4441 Fax: 870-735-5441 | |
Arnzie Johnson, MHP Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 252 Manor St, Marion, AR 72364 Phone: 870-739-6818 Fax: 870-739-6821 | |
Tangella Foreman, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 4001 Commercial Center Dr Ste 2, Marion, AR 72364 Phone: 870-732-7920 |